Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities
K Stamatopoulos, S Pavlova, O Al‐Sawaf… - …, 2024 - Wiley Online Library
Patients with chronic lymphocytic leukemia (CLL) exhibit diverse clinical outcomes. An
expanding array of genetic tests is now employed to facilitate the identification of patients …
expanding array of genetic tests is now employed to facilitate the identification of patients …
[HTML][HTML] Clinical source data production and quality control in real-world studies: proposal for development of the eSource record system
B Wang, J Lai, F Jin, X Liao, H Zhu… - JMIR Research …, 2022 - researchprotocols.org
Background: An eSource generally includes the direct capture, collection, and storage of
electronic data to simplify clinical research. It can improve data quality and patient safety and …
electronic data to simplify clinical research. It can improve data quality and patient safety and …
World Data in the Digital
I Apostolakis - Convergence of Population Health Management …, 2024 - books.google.com
Healthcare is undergoing a profound digital transformation globally. The integration of digital
technologies across healthcare is reshaping patient care and administrative processes. This …
technologies across healthcare is reshaping patient care and administrative processes. This …
The Added Value of Real-World Data in the Digital Health Ecosystem: Challenges in the Greek Context
K Konstantinidis, I Apostolakis - Convergence of Population Health …, 2025 - igi-global.com
Healthcare is undergoing a profound digital transformation globally. The integration of digital
technologies across healthcare is reshaping patient care and administrative processes. This …
technologies across healthcare is reshaping patient care and administrative processes. This …
[HTML][HTML] Trends in Population-Based Studies: Molecular and Digital Epidemiology
NS Denisov, EM Kamenskikh… - … технологии в медицине, 2022 - cyberleninka.ru
The development of high-throughput technologies has sharply increased the opportunities
to research the human body at the molecular, cellular, and organismal levels in the last …
to research the human body at the molecular, cellular, and organismal levels in the last …
[HTML][HTML] ТРЕНДЫ ПОПУЛЯЦИОННЫХ ИССЛЕДОВАНИЙ: МОЛЕКУЛЯРНАЯ И ЦИФРОВАЯ ЭПИДЕМИОЛОГИЯ (ОБЗОР)
НС Денисов, ЕМ Каменских… - … технологии в медицине, 2022 - cyberleninka.ru
В последнее десятилетие развитие высокопроизводительных технологий привело к
резкому увеличению возможностей изучения организма на молекулярном, клеточном и …
резкому увеличению возможностей изучения организма на молекулярном, клеточном и …
A Framework to Support the Standardized Management of Real-World Data
E Minga, T Chatzikonstantinou… - Digital Health and …, 2024 - ebooks.iospress.nl
Relying on our experience on the development of data registration and management
systems for clinical and biological data coming from patients with hematological …
systems for clinical and biological data coming from patients with hematological …
СОВРЕМЕННЫЕ ТЕХНОЛОГИИ В МЕДИЦИНЕ
НС Денисов, ЕМ Каменских… - СОВРЕМЕННЫЕ …, 2022 - elibrary.ru
В последнее десятилетие развитие высокопроизводительных технологий привело к
резкому увеличению возможностей изучения организма на молекулярном, клеточном и …
резкому увеличению возможностей изучения организма на молекулярном, клеточном и …
[HTML][HTML] CLL immune challenges and white paper
N York - clladvocates.net
Cast your minds back to the early stages of the COVID-19 pandemic–to the fear you may
have experienced, the uncertainty and the isolation as you were locked down and were …
have experienced, the uncertainty and the isolation as you were locked down and were …
[PDF][PDF] МИНИСТЕРСТВО ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ ФГБОУ ВО «ПЕРВЫЙ САНКТ-ПЕТЕРБУРГСКИЙ ГОСУДАРСТВЕННЫЙ …
ОБ КАЛАШНИКОВА, ИПХ ЛИМФОЛЕЙКОЗА - bloodscience.ru
Актуальность темы Хронический лимфолейкоз (ХЛЛ)—наиболее часто встречающийся
хронический лейкоз взрослых [160]. Биологическая гетерогенность заболевания лежит …
хронический лейкоз взрослых [160]. Биологическая гетерогенность заболевания лежит …